The actions of nicotine and cocaine in a mouse model of anxiety
Abstract
The acute administration of nicotine (0.01-1.0 mg/kg IP) to the mouse increased the time spent and rearings and line crossings in the aversive brightly illuminated white area of a two compartment white/black test box, with a corresponding decrease in the black. This profile of change was maintained during twice daily administration (0.1 mg/kg IP) for 14 days. Eight to 96 hr following withdrawal of nicotine (14-day treatment), the behavioural profile was reversed to a preference for the black area: by 240 hr values had returned to control levels. In contrast to the effects of nicotine, an acute injection of cocaine (0.1-10 mg/kg IP) exacerbated the aversive response to the white area. However, similarly to nicotine, the administration of cocaine (1.0 mg/kg IP) twice daily for 14 days reduced the aversion to the white area and exacerbated the response following cocaine withdrawal. The effects of nicotine and cocaine to reduce and enhance responsiveness to the aversive properties of the white area are discussed in terms of an anxiolytic and anxiogenic response and the possibility of a serotonergic involvement.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Nicotine withdrawal can elicit anxiety-like behaviors in mice.
“Nicotine withdrawal can elicit anxiety-like behaviors in mice [190–192].”
From Mechanistic insights into nicotine withdrawal (2011) · cites this paper as [190]
Cites
Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines
Crawley, J. N., & Goodwin, F. K. (1980) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(80)90067-2 · Cited by 1,432 · see citing works
Hernandez, L., & Hoebel, B. G. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90036-7 · Cited by 627 · see citing works
Exploration of mice in a black and white test box: Validation as a model of anxiety
Costall, B., Jones, B. J., Kelly, M. E., Naylor, R. J., & Tomkins, D. M. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90033-6 · Cited by 544 · see citing works
Self-citationCrawley, J. N. (1981) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(81)90007-1 · Cited by 508 · see citing works
Ellinwood, E. H., & Kilbey, M. M. (1977) · Advances in behavioral biology · doi:10.1007/978-1-4684-3087-5 · Cited by 429 · see citing works
Withdrawal reactions from chlordiazepoxide (?Librium?)
Hollister, L. E., Motzenbecker, F. P., & Degan, R. O. (1961) · Psychopharmacologia · doi:10.1007/bf00429621 · Cited by 340 · see citing works
Animal models of anxiety: the effect of compounds that modify 5-HT neurotransmission
Chopin, P., & Briley, M. (1987) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(87)90101-5 · Cited by 281 · see citing works
Benzodiazepines: Potentiation of a GABA inhibitory response in the dorsal raphe nucleus
Gallager, D. W. (1978) · European Journal of Pharmacology · doi:10.1016/0014-2999(78)90069-9 · Cited by 277 · see citing works
Neuropharmacology of Serotonin
Jenner, P. (1986) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.49.8.974 · Cited by 238 · see citing works
Christmas, A. J., & Maxwell, D. (1970) · Neuropharmacology · doi:10.1016/0028-3908(70)90044-4 · Cited by 188 · see citing works
Cigarette withdrawal symptoms in adolescent smokers
McNeill, A. D., West, R., Jarvis, M. J., Jackson, P., & Bryant, A. (1986) · Psychopharmacology · doi:10.1007/bf00174074 · Cited by 142 · see citing works
Benzodiazepine-GABA receptor-ionophore complex
Ticku, M. K. (1983) · Neuropharmacology · doi:10.1016/0028-3908(83)90114-4 · Cited by 131 · see citing works
File, S. E., Hyde, J. R. G., & MacLeod, N. K. (1979) · Journal of Affective Disorders · doi:10.1016/0165-0327(79)90030-2 · Cited by 121 · see citing works
Costall, B., Kelly, M. E., Naylor, R. J., Onaivi, E. S., & Tyers, M. B. (1989) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1989.tb11821.x · Cited by 110 · see citing works
Self-citationAnxiogenic properties of beta-CCE and FG 7142: a review of promises and pitfalls
Thi�bot, M.-H., Soubri�, P., & Sanger, D. J. (1988) · Psychopharmacology · doi:10.1007/bf00212837 · Cited by 105 · see citing works
Cocaine modulation of central monoaminergic neurotransmission
Pitts, D. K., & Marwah, J. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90147-x · Cited by 99 · see citing works
Thiébot, M.-H., Hamon, M., & Soubrié, P. (1982) · Neuroscience · doi:10.1016/0306-4522(82)90139-7 · Cited by 96 · see citing works
The Biological Basis of Benzodiazepine Actions
Haefely, W. E. (1983) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1983.10472119 · Cited by 89 · see citing works
Dwoskin, L. P., Peris, J., Yasuda, R. P., Philpott, K., & Zahniser, N. R. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90634-0 · Cited by 85 · see citing works
Actions of Buspirone in a Putative Model of Anxiety in the Mouse
Costall, B., Kelly, M. E., Naylor, R. J., & Onaivi, E. S. (1988) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1988.tb05284.x · Cited by 69 · see citing works
Self-citationAnxiogenic effects in benzodiazepine withdrawal are linked to the development of tolerance
File, S. E., Baldwin, H. A., & Aranko, K. (1987) · Brain Research Bulletin · doi:10.1016/0361-9230(87)90079-7 · Cited by 64 · see citing works
Neuroanatomical substrates of anxiety: a brief survey
Kuhar, M. J. (1986) · Trends in Neurosciences · doi:10.1016/0166-2236(86)90089-5 · Cited by 59 · see citing works
Anxiogenic properties of cocaine withdrawal
Wood, D. M., & Lal, H. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90619-9 · Cited by 59 · see citing works
The effects of nicotine administration on 5-HT uptake and biosynthesis in rat brain
Benwell, M. E. M., & Balfour, D. J. K. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90158-3 · Cited by 58 · see citing works
Chronic ethanol or nicotine treatment results in partial cross-tolerance between these agents
Burch, J. B., de Fiebre, C. M., Marks, M. J., & Collins, A. C. (1988) · Psychopharmacology · doi:10.1007/bf00172954 · Cited by 55 · see citing works
Anxiogenic aspects of diazepam withdrawal can be detected in animals
Emmett‐Oglesby, M. W., Spencer, D. G., Lewis, M. L., et al. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90117-6 · Cited by 54 · see citing works
The Anxiolytic and Anxiogenic Actions of Ethanol in a Mouse Model
Costall, B., Kelly, M. E., & Naylor, R. J. (1988) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1988.tb05218.x · Cited by 53 · see citing works
Self-citationThe effect of chronic cocaine on self-stimulation train-duration thresholds
Frank, R. A., Martz, S. A., & Pommering, T. L. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90199-2 · Cited by 53 · see citing works
Effects of chronic nicotine administration on the response and adaptation to stress
Benwell, M. E. M., & Balfour, D. J. K. (1982) · Psychopharmacology · doi:10.1007/bf00435271 · Cited by 52 · see citing works
Balfour, D. J. K., Graham, C. A., & Vale, A. L. (1986) · Psychopharmacology · doi:10.1007/bf00174073 · Cited by 52 · see citing works
Interaction of RO 15-4513 and ethanol on the behaviour of mice: antagonistic or additive effects?
Misslin, R., Belzung, C., & Vogel, E. (1988) · Psychopharmacology · doi:10.1007/bf00174695 · Cited by 52 · see citing works
Cocaine interaction withc entral monoaminergic systems: electrophysiological approaches
Lakoski, J. M., & Cunningham, K. A. (1988) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(88)90034-x · Cited by 52 · see citing works
Belzung, C., Misslin, R., & Vogel, E. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90043-4 · Cited by 40 · see citing works
Dependence liability of the benzodiazepines
Ladewig, D. (1984) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(84)90054-1 · Cited by 40 · see citing works
Withdrawal syndrome following subchronic treatment with anxiolytic agents
Barry, J. M., Costall, B., Kelly, M. E., et al. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90565-x · Cited by 38 · see citing works
Self-citationHindley, S. W., Hobbs, A., Paterson, I. A., et al. (1985) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1985.tb08955.x · Cited by 24 · see citing works
Jones, B. J., Paterson, I. A., & Roberts, M. H. T. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90216-9 · Cited by 19 · see citing works
Differential effects of cocaine on limbic excitability
Lesse, H., & Collins, J. P. (1980) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(80)90014-3 · Cited by 19 · see citing works
COHEN, S. S. (1975) · JAMA · doi:10.1001/jama.231.1.74 · Cited by 18 · see citing works
Resnick, R. B., Kestenbaum, R. S., & Schwartz, L. K. (1977) · Advances in behavioral biology · doi:10.1007/978-1-4684-3087-5_30 · Cited by 17 · see citing works
Drug effects on a measure of unconditioned avoidance in the rat
Morrison, C. F., & Stephenson, J. A. (1970) · Psychopharmacology · doi:10.1007/bf00401495 · Cited by 14 · see citing works
Reduction of nicotine-induced hyperactivity by pCPA
FitzGerald, R., Oettinger, R., & Bättig, K. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90570-2 · Cited by 14 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Effect of nicotine and nicotinic receptors on anxiety and depression
Picciotto, M. R., Brunzell, D. H., & Caldarone, B. J. (2002) · Neuroreport · doi:10.1097/00001756-200207020-00006 · Cited by 483 · see citing works
Anxiety, anxiety disorders, tobacco use, and nicotine: A critical review of interrelationships.
Morissette, S. B., Tull, M. T., Gulliver, S. B., Kamholz, B. W., & Zimering, R. T. (2007) · Psychological Bulletin · doi:10.1037/0033-2909.133.2.245 · Cited by 380 · see citing works
Nicotinic receptors in the brain. Links between molecular biology and behavior
Picciotto, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00146-3 · Cited by 354 · see citing works
Picciotto, M. R., Caldarone, B. J., Brunzell, D. H., Zachariou, V., Stevens, T. R., & King, S. L. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00161-9 · Cited by 221 · see citing works
Ross, S. A., Wong, J. Y. F., Clifford, J. J., Kinsella, A., Massalas, J. S., Horne, M. K., Scheffer, I. E., Kola, I., Waddington, J. L., Berkovic, S. F., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06431.2000 · Cited by 204 · see citing works
Malin, D. H. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00699-2 · Cited by 167 · see citing works
Fowler, C. D., Arends, M. A., & Kenny, P. J. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830c360e · Cited by 131 · see citing works
Ouagazzal, A.-M., Kenny, P. J., & File, S. E. (1999) · Psychopharmacology · doi:10.1007/s002130050976 · Cited by 121 · see citing works
Common aspects of the action of nicotine and other drugs of abuse
Picciotto, M. R. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00074-x · Cited by 117 · see citing works
Cheeta, S., Irvine, E. E., Kenny, P. J., & File, S. E. (2001) · Psychopharmacology · doi:10.1007/s002130100681 · Cited by 113 · see citing works
Tolerance to nicotine's effects in the elevated plus-maze and increased anxiety during withdrawal
Irvine, E. E., Cheeta, S., & File, S. E. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00449-4 · Cited by 88 · see citing works
Nicotine and endogenous opioids: neurochemical and pharmacological evidence
Hadjiconstantinou, M., & Neff, N. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.11.010 · Cited by 81 · see citing works
Social isolation modifies nicotine's effects in animal tests of anxiety
Cheeta, S., Irvine, E., & File, S. E. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703991 · Cited by 71 · see citing works
Mechanistic insights into nicotine withdrawal
Paolini, M., & De Biasi, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.075 · Cited by 66 · see citing works
Decreased anxiety-like behavior in beta3 nicotinic receptor subunit knockout mice
Booker, T. K., Butt, C. M., Wehner, J. M., Heinemann, S. F., & Collins, A. C. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.04.011 · Cited by 49 · see citing works
Tucci, S., Cheeta, S., Seth, P., & File, S. E. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1403-4 · Cited by 38 · see citing works
Anxiolytic effects of nicotine in a rodent test of approach-avoidance conflict
Cohen, A., Young, R. W., Velazquez, M. A., Groysman, M., Noorbehesht, K., Ben-Shahar, O. M., & Ettenberg, A. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1486-7 · Cited by 36 · see citing works
Mild anxiogenic effects of nicotine withdrawal in mice
Jonkman, S., Henry, B., Semenova, S., & Markou, A. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.04.032 · Cited by 35 · see citing works
Divergent Functional Effects of Sazetidine-A and Varenicline During Nicotine Withdrawal
Turner, J. R., Wilkinson, D. S., Poole, R. L., Gould, T. J., Carlson, G. C., & Blendy, J. A. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.105 · Cited by 29 · see citing works
- Authors
- Costall, B., Elizabeth Kelly, M., Naylor, R. J., & Onaivi, E. S.
- Affiliations
- University of Bradford (GB)
- Corresponding author
- Naylor, Robert J.
- ORCID
- Onaivi, Emmanuel S.
- Venue
- Pharmacology Biochemistry and Behavior
- Publisher
- Elsevier BV
- Published
- 1989-05
- Volume
- 33
- Issue
- 1
- Pages
- 197-203
- ISSN
- 0091-3057 (ISSN-L)
- OpenAlex
- W2084436311
- Cited by
- 186
- References
- 42
- Citations by year
- 2023: 1 · 2022: 2 · 2021: 1 · 2020: 5 · 2017: 3 · 2016: 1 · 2015: 3 · 2014: 3 · 2013: 6 · 2012: 5
- FWCI
- 1.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pharmacology Biochemistry and Behavior (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Keywords
- nicotine, cocaine, anxiety, aversive behavior, nicotine withdrawal, cocaine withdrawal, anxiolytic effects, anxiogenic effects, self-administration
- MeSH terms
- Animals, Anxiety, Behavior, Animal, Cocaine, Discrimination, Psychological, Disease Models, Animal, Light, Male, Mice, Inbred Strains, Nicotine, Substance Withdrawal Syndrome, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review